LENSAR (LNSR) vs Outset Medical (OM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
LENSAR (LNSR) has outperformed Outset Medical (OM) over the past year, losing 47.0% versus a loss of 74.1%. Over five years, LNSR leads with a -14.2% price change compared with -99.4% for OM. LENSAR is the larger company by market cap ($78.9 million vs $75.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LNSR | OM |
|---|---|---|
| Share price | $6.42 | $4.04 |
| Market cap | $78.88M | $75.94M |
| 1-day change | -0.47% | -1.22% |
| YTD return | -44.54% | +10.24% |
| 1-year return | -47.04% | -74.13% |
| 5-year return | -14.23% | -99.44% |
| P/E ratio (TTM) | 35.67 | — |
| EPS (TTM) | $0.18 | $-4.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.94 | $15.94 |
| 52-week low | $4.95 | $2.84 |
| Distance from 52-week high | -50.39% | -74.65% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +76.48% | +89.85% |
| Average volume | 102.04K | 158.75K |
| Shares outstanding | 12.29M | 18.80M |
| Employees | 150 | 310 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LNSR has outperformed OM by 27.1 percentage points over the past year.
About LENSAR
LNSR stock →LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision.
Health Care · Medical/Dental Instruments · 150 employees
About Outset Medical
OM stock →Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 310 employees
LNSR vs OM FAQ
Which is bigger, LENSAR or Outset Medical?
LENSAR (LNSR) is larger, with a market capitalization of $78.88M compared with $75.94M for Outset Medical (OM).
Which stock has performed better over the past year, LNSR or OM?
LNSR returned -47.04% over the past 12 months, compared with -74.13% for OM (price return, excluding dividends). Past performance does not predict future results.
Are LENSAR and Outset Medical in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for LENSAR and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Outset Medical.